Jaguar Health, Inc. (JAGX) SEC Filing 8-K Material Event for the period ending Tuesday, October 1, 2019

Jaguar Health, Inc.

CIK: 1585608 Ticker: JAGX

View differences made from one to another to evaluate Jaguar Health, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Jaguar Health, Inc..


Assess how Jaguar Health, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Jaguar Health, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Jaguar Health, Inc. provided additional information to their SEC Filing as exhibits

Ticker: JAGX
CIK: 1585608
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-053249
Submitted to the SEC: Mon Oct 07 2019 4:31:11 PM EST
Accepted by the SEC: Mon Oct 07 2019
Period: Tuesday, October 1, 2019
Industry: Pharmaceutical Preparations
  1. Ending Agreement
  2. Financial Exhibit
  3. New Agreement
  4. New Financial Obligation
  5. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: